Ameliorative effect of allopurinol on nonbacterial prostatitis: a parallel double-blind controlled study
- PMID: 8583618
Ameliorative effect of allopurinol on nonbacterial prostatitis: a parallel double-blind controlled study
Abstract
Purpose: Nonbacterial prostatitis is a common problem in young men. It is a disease that is often recurrent and each episode lasts for several months. Different causative mechanisms of the disease have been discussed, including identified and unidentified microorganisms, stone formation and psychological factors. We have demonstrated in a previous study that urinary reflux (as shown by a high creatinine concentration in prostatic fluid) occurs to a varying extent into the prostatic ducts, and this reflux has been related to prostatic pain and urate concentration in expressed prostatic secretion.
Materials and methods: We performed a paralled double-blind controlled study of the objective and subjective effects of allopurinol on patients with nonbacterial prostatitis. Twenty patients received placebo, 18 received 300 mg. allopurinol daily and 16 received 600 mg allopurinol daily for 240 days. All patients began medication at the same time regardless of whether the disease was in an active state. No side effects were noted in the treatment groups.
Results: Significant effects were noted on the concentrations of serum urate, urine urate, expressed prostatic secretion urate, expressed prostatic secretion xanthine and subjective discomfort.
Conclusions: Allopurinol has a significant, positive effect on nonbacterial prostatitis. It is safe and worthy of trial for all at least a 3-month period at each episode to relieve the symptoms of nonbacterial prostatitis.
Comment in
-
Re: Ameliorative effect of allopurinol on nonbacterial prostatitis: a parallel double-blind controlled study.J Urol. 1997 Feb;157(2):628-9. doi: 10.1016/s0022-5347(01)65229-7. J Urol. 1997. PMID: 8996380 No abstract available.
Similar articles
-
Allopurinol treatment results in elevated prostate-specific antigen levels in prostatic fluid and serum of patients with non-bacterial prostatitis.Eur Urol. 1996;29(1):111-4. doi: 10.1159/000473728. Eur Urol. 1996. PMID: 8821701
-
Evidence for a mechanistic association between nonbacterial prostatitis and levels of urate and creatinine in expressed prostatic secretion.J Urol. 1996 Mar;155(3):958-60. J Urol. 1996. PMID: 8583617
-
Effect of allopurinol in chronic nonbacterial prostatitis: a double blind randomized clinical trial.Int Braz J Urol. 2006 Mar-Apr;32(2):181-6. doi: 10.1590/s1677-55382006000200008. Int Braz J Urol. 2006. PMID: 16650295 Clinical Trial.
-
Nonbacterial prostatitis: a comprehensive review.Urol Int. 1991;46(2):121-5. doi: 10.1159/000282115. Urol Int. 1991. PMID: 2053217 Review.
-
Strategies for the Treatment of Prostatitis.J Infect Chemother. 1997;3(4):184-189. doi: 10.1007/BF02490032. Epub 2014 Apr 5. J Infect Chemother. 1997. PMID: 29681340 Review. No abstract available.
Cited by
-
An evidence-based approach to the treatment of prostatitis: is it possible?Curr Urol Rep. 2000 Aug;1(2):142-7. doi: 10.1007/s11934-000-0049-6. Curr Urol Rep. 2000. PMID: 12084328 Review.
-
Chronic prostatitis.West J Med. 2000 Feb;172(2):98-101. doi: 10.1136/ewjm.172.2.98. West J Med. 2000. PMID: 18751239 Free PMC article. No abstract available.
-
Chronic prostatitis.BMJ Clin Evid. 2011 Jul 4;2011:1802. BMJ Clin Evid. 2011. PMID: 21736764 Free PMC article.
-
The New Age of Prostatitis.Curr Infect Dis Rep. 2001 Dec;3(6):534-539. doi: 10.1007/s11908-001-0091-7. Curr Infect Dis Rep. 2001. PMID: 11722811
-
Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.Cochrane Database Syst Rev. 2019 Oct 6;10(10):CD012552. doi: 10.1002/14651858.CD012552.pub2. Cochrane Database Syst Rev. 2019. PMID: 31587256 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources